Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States.
Saved in:
| Title: | Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States. |
|---|---|
| Authors: | Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA., Sy LS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Ackerson BK; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Rayens E; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Wu J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Cheng Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Ku JH; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii, USA., Vega Daily LI; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Takhar HS; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Song J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA., Cohen RA; GSK, Rockville, Maryland, USA., Yun H; GSK, Rockville, Maryland, USA., Oraichi D; GSK, Rockville, Maryland, USA., Seifert H; GSK, Rockville, Maryland, USA., Qian L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. |
| Source: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 04; Vol. 81 (6), pp. e717-e726. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40581370 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tseng+HF%22">Tseng HF</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.; Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Sy+LS%22">Sy LS</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Ackerson+BK%22">Ackerson BK</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Rayens+E%22">Rayens E</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Wu+J%22">Wu J</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Cheng+Y%22">Cheng Y</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Ku+JH%22">Ku JH</searchLink>; Center for Integrated Health Care Research, Kaiser Permanente Hawaii, Honolulu, Hawaii, USA.<br /><searchLink fieldCode="AU" term="%22Vega+Daily+LI%22">Vega Daily LI</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Takhar+HS%22">Takhar HS</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Song+J%22">Song J</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Cohen+RA%22">Cohen RA</searchLink>; GSK, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Yun+H%22">Yun H</searchLink>; GSK, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Oraichi+D%22">Oraichi D</searchLink>; GSK, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Seifert+H%22">Seifert H</searchLink>; GSK, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Qian+L%22">Qian L</searchLink>; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229203213%22">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</searchLink> [Clin Infect Dis] 2026 Feb 04; Vol. 81 (6), pp. e717-e726. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9203213 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6591 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210584838%22">10584838 </searchLink><i>NLM ISO Abbreviation: </i>Clin Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40581370 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/cid/ciaf329 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e717 Titles: – TitleFull: Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Adults ≥50 Years in the United States. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tseng HF – PersonEntity: Name: NameFull: Sy LS – PersonEntity: Name: NameFull: Ackerson BK – PersonEntity: Name: NameFull: Rayens E – PersonEntity: Name: NameFull: Wu J – PersonEntity: Name: NameFull: Luo Y – PersonEntity: Name: NameFull: Cheng Y – PersonEntity: Name: NameFull: Ku JH – PersonEntity: Name: NameFull: Vega Daily LI – PersonEntity: Name: NameFull: Takhar HS – PersonEntity: Name: NameFull: Song J – PersonEntity: Name: NameFull: Cohen RA – PersonEntity: Name: NameFull: Yun H – PersonEntity: Name: NameFull: Oraichi D – PersonEntity: Name: NameFull: Seifert H – PersonEntity: Name: NameFull: Qian L IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 02 Text: 2026 Feb 04 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1537-6591 Numbering: – Type: volume Value: 81 – Type: issue Value: 6 Titles: – TitleFull: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Type: main |
| ResultId | 1 |